FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
Screening for lung cancer using low-dose computed tomography (CT) was introduced in the United States in 2013. Recent data...
By Meghali Goswami Meghali Goswami is a PhD candidate in the George Washington University – National Institutes of Health Graduate Partnerships Program and is currently...
Each spring, the American Association for Cancer Research (AACR) brings a group of AACR Associate members to Washington, D.C.,...
The incidence of colorectal cancer – the fourth most common cancer diagnosed in the United States – has been...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
February is drawing to a close, and it’s time for our monthly staple: the collection of 10 “must read”...
“There’s a clear connection between cancer and the gut microbiome,” began Matthew Redinbo, PhD, at the opening keynote address...